跳至主要内容
临床试验/NL-OMON42302
NL-OMON42302已完成2 期

Pharmacokinetics of two high dose regimes of intravenous vitamin C in critically ill patients - Pharmacokinetics of intravenous vitamin C in critically ill patient

Vrije Universiteit Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Sepsis or SIRS (systemic inflammatory response syndrome), after major surgery or trauma
  • Non-neurological sequential organ failure score (SOFA) >6
  • Expected length of ICU stay >96 hours
  • Informed consent initially the legal representative and later by the patient

排除标准

  • Admission after out of hospital cardiac arrest
  • Prior use of supplemental vitamin C in the week before
  • Major bleeding
  • Pre-existent renal insufficiency defined as an eGFR < 30 ml/min/1.73 m2 (stadium 4-5)
  • Expected need for renal replacement therapy within 48 hours
  • Known glucose 6-phosphate dehydrogenase deficiency
  • History of urolithiasis or oxalate nephropathy
  • Previous use of prolonged high dose vitamin C supplements
  • Hemochromatosis

研究者

相似试验